Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th

Live webcast beginning at 8:30am EDT / 2:30pm CEST


Saint Herblain (France), June 11, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet medical needs, today announced that it will host a Research & Development (R&D) Investor Day on Tuesday, July 9th, 2019 in New York City, from 8:30a.m. to 11:00a.m. Eastern Daylight Time (EDT).

Read more